MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

Returns on capital

MiniMed Group, Inc. Common Stock management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-9.2%

avg -5.0%

ROIC

1.2%

avg -1.6%

ROA

-7.1%

avg -4.0%

Analysis

ROIC is currently the strongest return metric at 1.2% versus its period average of -1.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Chad J. Spooner

Executive VP & CFOUSD 5.82M54——

Que Thanh Dallara

CEO & DirectorUSD 1.86M52——

Ali Dianaty

Executive VP and Chief Product & Technology OfficerUSD 1.56M51325.82K0.12%

Gillian Chandrasena

Senior VP & Chief Human Resources OfficerUSD 1.32M52174.54K0.06%

Courtney Nelson Wills

Senior VP, General Counsel & Corporate SecretaryUSD 850.19K50136.38K0.05%

Sheila A. Denton

Senior VP, General Counsel & Corporate SecretaryUSD 850.19K6058.94K0.02%

Kate Cronin

SVP and Chief Marketing & Communications Officer—60——

Mike Bruggeman

SVP & Chief Information Officer————

Ryan Weispfenning

Head of Investor Relations————

Slobodan Radumilo

SVP & Chief Commercial Officer of EMEA and APAC—55——

Yael Glassman

SVP, Chief Strategy & Corporate Development Officer————

Christopher E. Eso

President————

John Gyurci

VP, Chief Accounting Officer & Controller—5539.94K0.01%

Compensation is shown in the reported currency; data updated Nov 18, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 28, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+11.4%
+8.1% (6yr)3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
+24.3% (6yr)3 analysts

Analysis

Recent growth has been strongest in Revenue at +11.4% over three years. Forward estimates point to EBIT at +24.3% (6yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does MiniMed Group, Inc. Common Stock compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about MMED's management, answered from reported figures.

Who manages MMED?

MiniMed Group, Inc. Common Stock (MMED) lists 13 active executives. The top listed executive is Courtney Nelson Wills, Senior VP, General Counsel & Corporate Secretary.

Are MMED insiders buying or selling?

Recent insider activity shows net buying of $9.78M.